Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: Valeant sells development programs

By admin

Created Dec 21 2006 - 7:01pm

Valeant Pharmaceuticals has sold the rights to its HIV and cancer development programs to Ardea Biosciences. Report [1]

Source URL: http://www.fiercebiotech.com/story/spotlight-valeant-sells-development-programs/2006-12-22

Links:
[1] http://www.streetinsider.com/Mergers+and+Acquisitions/Valeant+Phama+(VRX)+Sells+Discovery+and+Preclinical+Assets+to+Ardea/1450836.html